OncoCyte Posts Higher Q4 Net Loss – 360Dx

Spread the love

OncoCyte Posts Higher Q4 Net Loss 360Dx

NEW YORK (GenomeWeb) – Liquid biopsy test developer OncoCyte on Monday reported a 13 percent increase in its fourth quarter net loss as higher …

…read more

Source:: Alameda, California News By Google News

[ghozylab-instagram feed=26796]